In this study, we found that BMFs contributed to the anti-PD-L1 (aPD-L1) antibody immunotherapy resistance via the upregulated expression of PD-L1 in BMFs, which was mediated by the crosstalk between BMFs and cancer cells. This evidence concerns the gene CD274 and cancer.